I am issuing a call to action to the FDA, to industry, and to all Members of Congress, but most especially our committee, to take these problems seriously and work together on a bipartisan basis to address them.
Anna Eshoo: “I am issuing a call to action to the FDA, to industry, and to all Members of Congress, but most especially our…”
On the recordOctober 29, 2019
Source
congress.govEditor's note · Context
Eshoo emphasizes the need for bipartisan action to address drug supply issues.
Share
More from Anna Eshoo
Apr 25, 2023
I find it hypocritical when I hear time and time and time again that plans are often blocked by PBMs from offering the lowest-priced generic.
Apr 17, 2023
I support a robust FAA Reauthorization bill that will benefit the Hollywood Burbank Airport.
Dec 11, 2023
I thank the ranking member of the full committee for yielding time. Today, the House is going to vote on my legislation, H.R. 3226, the PREEMIE Reauthorization Act. I thank the co-leads of this legislation: Representatives Miller-Meeks…
Apr 18, 2023
I support the legislation we are considering today to permanently authorize the THC GME program and fund new training sites to increase resident physician spots.





